When researchers begin exploring the peptide space, two compounds come up repeatedly: BPC-157 and TB-500. Both have accumulated substantial research interest over the past two decades, and both are available as lyophilized powder for research purposes. But they're distinct compounds with different mechanisms, different molecular profiles, and different research applications.
What Is BPC-157?
BPC-157 — short for Body Protection Compound-157 — is a synthetic pentadecapeptide derived from a protein found in gastric juice. Its full sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, and it has a molecular weight of approximately 1,419 Da.
Research into BPC-157 has focused primarily on its interactions with growth hormone receptors and its effects on angiogenesis — the formation of new blood vessels. Studies conducted in animal models have examined its role in tissue repair contexts, particularly in tendon, ligament, and gastrointestinal tissue.
BPC-157 is notable for its stability in gastric acid, which has made it a subject of interest for oral administration research, though most research protocols use subcutaneous or intramuscular delivery.
What Is TB-500?
TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide found in virtually all human and animal cells. The full-length Thymosin Beta-4 is a 43-amino acid protein; TB-500 is a shorter, active fragment — specifically the actin-binding domain — that retains much of the biological activity of the parent molecule.
Research into TB-500 has centered on its role in actin regulation. Actin is a structural protein critical to cell motility, wound healing, and tissue repair. TB-500's ability to bind G-actin (monomeric actin) and regulate its availability has made it a subject of interest in studies examining cellular migration and tissue regeneration.
How BPC-157 and TB-500 Differ
While both peptides are frequently discussed together in research contexts, they operate through distinct mechanisms. BPC-157 primarily interacts with the growth hormone receptor pathway and has demonstrated effects on nitric oxide synthesis in research models. TB-500 works through actin regulation — specifically sequestering G-actin to modulate cell motility and migration.
TB-500 is larger (2,113 Da vs. 1,419 Da for BPC-157), which affects reconstitution protocols and dosing calculations in research settings. BPC-157 research has concentrated heavily on gastrointestinal and tendon tissue, while TB-500 research has focused more broadly on wound healing, cardiac tissue, and corneal repair in animal models.
What Researchers Look for When Sourcing These Peptides
Purity is the single most important variable when sourcing research peptides. A compound at 95% purity is not the same as a compound at 99% purity — the 4% difference represents unknown impurities that can confound research results and make data unreliable.
Third-party testing is non-negotiable. A Certificate of Analysis (COA) from an independent laboratory — not self-reported by the supplier — is the baseline standard for any serious research application. The COA should specify the testing method (HPLC is the gold standard), the purity percentage, and the batch number.
Storage and Reconstitution Notes
Both BPC-157 and TB-500 are supplied as lyophilized (freeze-dried) powder, which provides maximum stability during shipping and storage. Store lyophilized peptides at -20°C for long-term storage. Once reconstituted, store at 4°C and use within 30 days. Both peptides are water-soluble and typically reconstituted with bacteriostatic water (BAC water).
At Bluegrass Research, every batch of BPC-157 and TB-500 is independently tested to ≥99% purity using HPLC analysis. The COA for each batch is available on our COA page and ships with every order.